 |
|
|
|
|
|
|
| Article 1 to 10 out of 18 concerning Boehringer Ingelheim Pharma GmbH & Co. KG
|
-
Boehringer Ingelheim microParts to expand production capacity in Dortmund
(26 Mar 2007)
Boehringer Ingelheim microParts GmbH laid the foundation stone for an additional production building at the site in Dortmund. The new building - a state-of-the-art factory for the worldwide inhaler production - is set to cost a total of 70 million ...
-
Boehringer Ingelheim and IdeaSphere announce acquisition deal
(29 Aug 2006)
Pharmaton business will be taken over by the American health care specialist
Boehringer Ingelheim and IdeaSphere Inc. (ISI) announced the sale of Boehringer Ingelheim´s Natural Healthcare company and business Pharmaton SA (Lugano) to IdeaSphere. Financial terms of the transaction were not disclosed."IdeaSphere has been ...
-
Boehringer Ingelheim to acquire STEAG microParts GmbH
(16 Sep 2004)
Boehringer Ingelheim is to acquire the microtechnology specialist STEAG microParts GmbH from STEAG AG, Essen, Germany. STEAG microParts, established in 1990, is a worldwide leader in microsystem technology with headquarters at the hub of technology ...
-
Strong international growth at Boehringer Ingelheim
(19 Aug 2004)
Excellent US business delivered the pharmaceutical group Boehringer Ingelheim strong growth in the first six months of 2004. Sales were up by almost 7 percent at EUR 3.7 billion. Operating income was 25 percent higher against the previous year. "We ...
-
Strong growth in human resources at Boehringer Ingelheim
(09 Apr 2003)
Ingelheim, Germany, 8 April 2003 - Boehringer Ingelheim increased its manpower appreciably last business year, while investing in new vacancies for trainees and training labs at the Ingelheim and Biberach sites. Professor Marbod Muff, member of the ...
-
Boehringer Ingelheim Opens New Production Plant in China
(04 Mar 2002)
Ingelheim, Germany/ Shanghai, China, 4th March, 2002 - Boehringer Ingelheim's operating unit Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd in China officially opened today a new manufacturing facility in Pudong Zhangjiang High Tech. Park in ...
-
Boehringer Ingelheim and Structural Bioinformatics, Inc. agree on research collaboration involving new anti-HIV compound/leads
(18 Dec 2001)
Boehringer Ingelheim (Canada) Ltd. and Structural Bioinformatics, Inc. (SBI) have agreed on a research collaboration to use SBI?s Variome? database for Boehringer Ingelheim?s in silico drug discovery of HIV protein targets. Variome? is a structural ...
-
World AIDS Day 2001 - Progress in the Battle against AIDS
(03 Dec 2001)
On World AIDS Day 2001, Boehringer Ingelheim reports on the successful progress of its initiatives in the battle against HIV/AIDS in the developing world. Since the delivery of drug supplies to Congo (Brazzaville) and Senegal as the first ...
-
Boehringer Ingelheim and ImmunoGen Sign Exclusive License Agreement
(29 Nov 2001)
Boehringer Ingelheim International GmbH and ImmunoGen, Inc. (Nasdaq: IMGN) today announced a collaboration to develop a new product combining ImmunoGen’s maytansinoid Tumor-Activated Prodrug (TAP) technology with a Boehringer Ingelheim ...
-
BOEHRINGER INGELHEIM RECEIVES FIRST MARKETING AUTHORIZATION FOR SPIRIVA® (TIOTROPIUM)
(18 Oct 2001)
Boehringer Ingelheim announced today that it has received an approval from the Medicinal Evaluation Board in Den Haag, Netherlands for its COPD drug Spiriva® (tiotropium). Spiriva’s approved indication is for the maintenance treatment of ...
|
|
|
|
|
Top